Intervention

Spironolactone 25mg

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

Unmitigated Aldosterone Signaling During Standard Clinical MRA DosingNCT07281014 · 2026-01-27

ACTIVE_NOT_RECRUITING

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic ResistanceNCT02585843 · 2015-11-01

Spironolactone in Adult Congenital Heart DiseaseNCT01069510 · 2010-02-01

Common conditions

Heart Failure3 Congenital Heart Disease1 Endomyocardial Fibrosis1

Leading sponsors

Columbia University1 Oregon Health and Science University1 Yale University1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE22

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.